FDA Approved: VIVITROL — Supplemental Application (Alkermes, Inc.)

View source ↗

Summary

FDA approved a supplemental application for VIVITROL (naltrexone) from Alkermes, Inc., resulting in an updated/expanded approval.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Dependence
• Opioid Dependence

Drugs mentioned

• Vivitrol (naltrexone extended-release injectable)

Snippet

SUPPL AP for VIVITROL (NALTREXONE)